US6585763B1
(en)
*
|
1997-10-14 |
2003-07-01 |
Vascusense, Inc. |
Implantable therapeutic device and method
|
US6775574B1
(en)
*
|
1997-11-07 |
2004-08-10 |
Medtronic, Inc. |
Method and system for myocardial infarction repair
|
AU733053C
(en)
|
1998-02-24 |
2001-11-29 |
Boston Scientific Limited |
High flow rate dialysis catheters and related methods
|
AU3973599A
(en)
*
|
1998-05-08 |
1999-11-29 |
Genetronics, Inc. |
Electrically induced vessel vasodilation
|
US6300108B1
(en)
|
1999-07-21 |
2001-10-09 |
The Regents Of The University Of California |
Controlled electroporation and mass transfer across cell membranes
|
US20060127466A1
(en)
*
|
2000-02-25 |
2006-06-15 |
Arindam Sen |
Method for transdermal or intradermal delivery of molecules
|
AU2001241958A1
(en)
*
|
2000-03-03 |
2001-09-17 |
Valentis, Inc. |
Improved poloxamer and poloxamine compositions for nucleic acid delivery
|
US6697670B2
(en)
|
2001-08-17 |
2004-02-24 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation with improved comfort of patients
|
US6795728B2
(en)
|
2001-08-17 |
2004-09-21 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits by electroporation
|
US8251986B2
(en)
|
2000-08-17 |
2012-08-28 |
Angiodynamics, Inc. |
Method of destroying tissue cells by eletroporation
|
US6892099B2
(en)
|
2001-02-08 |
2005-05-10 |
Minnesota Medical Physics, Llc |
Apparatus and method for reducing subcutaneous fat deposits, virtual face lift and body sculpturing by electroporation
|
USRE42016E1
(en)
|
2001-08-13 |
2010-12-28 |
Angiodynamics, Inc. |
Apparatus and method for the treatment of benign prostatic hyperplasia
|
US6994706B2
(en)
|
2001-08-13 |
2006-02-07 |
Minnesota Medical Physics, Llc |
Apparatus and method for treatment of benign prostatic hyperplasia
|
AU2002348417B9
(en)
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
US6733518B2
(en)
|
2001-10-31 |
2004-05-11 |
Seacoast Technologies, Inc. |
Method and apparatus for thermal therapy
|
US7211083B2
(en)
*
|
2003-03-17 |
2007-05-01 |
Minnesota Medical Physics, Llc |
Apparatus and method for hair removal by electroporation
|
US7261882B2
(en)
|
2003-06-23 |
2007-08-28 |
Reagents Of The University Of Colorado |
Methods for treating neuropathic pain by administering IL-10 polypeptides
|
EP1660530A2
(de)
|
2003-08-04 |
2006-05-31 |
Advisys, Inc. |
Für canine spezifisches wachstumshormon freisetzendes hormon
|
JP5138229B2
(ja)
|
2003-12-24 |
2013-02-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
不可逆的電気穿孔による組織アブレーション
|
US8298222B2
(en)
|
2003-12-24 |
2012-10-30 |
The Regents Of The University Of California |
Electroporation to deliver chemotherapeutics and enhance tumor regression
|
ATE467417T1
(de)
|
2003-12-31 |
2010-05-15 |
VGX Pharmaceuticals LLC |
Reduzierung von arthritis und lahmheit bei personen unter supllement von wachstumshormon freisetzendem hormon (ghrh)
|
EP1713828B1
(de)
|
2004-01-20 |
2011-04-27 |
VGX Pharmaceuticals, LLC |
Erhöhte sekretion/retention von wachstumshormonfreisetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid
|
US7840263B2
(en)
|
2004-02-27 |
2010-11-23 |
Cardiac Pacemakers, Inc. |
Method and apparatus for device controlled gene expression
|
US7764995B2
(en)
|
2004-06-07 |
2010-07-27 |
Cardiac Pacemakers, Inc. |
Method and apparatus to modulate cellular regeneration post myocardial infarct
|
US7729761B2
(en)
|
2004-07-14 |
2010-06-01 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlled gene or protein delivery
|
EP2816118B1
(de)
|
2005-05-31 |
2018-10-17 |
The Regents of the University of Colorado, a body corporate |
Verfahren zur Bereitstellung von Genen
|
US8114070B2
(en)
*
|
2005-06-24 |
2012-02-14 |
Angiodynamics, Inc. |
Methods and systems for treating BPH using electroporation
|
US20060293730A1
(en)
|
2005-06-24 |
2006-12-28 |
Boris Rubinsky |
Methods and systems for treating restenosis sites using electroporation
|
JP2009529930A
(ja)
*
|
2006-03-13 |
2009-08-27 |
ノボ・ノルデイスク・エー/エス |
二目的通信手段を備えた医療システム
|
CN101401313B
(zh)
|
2006-03-13 |
2014-06-11 |
诺沃—诺迪斯克有限公司 |
用于使用成双通信装置的电子设备的安全配对的系统
|
WO2008006019A2
(en)
|
2006-07-06 |
2008-01-10 |
Advisys Inc. |
Growth hormone releasing hormone treatment to decrease cholesterol levels
|
EP2076313A4
(de)
|
2006-10-16 |
2012-07-25 |
Univ California |
Gele mit vordefinierter leitfähigkeit zur endgültigen elektroporation eines gewebes
|
US20090247933A1
(en)
|
2008-03-27 |
2009-10-01 |
The Regents Of The University Of California; Angiodynamics, Inc. |
Balloon catheter method for reducing restenosis via irreversible electroporation
|
US10702326B2
(en)
|
2011-07-15 |
2020-07-07 |
Virginia Tech Intellectual Properties, Inc. |
Device and method for electroporation based treatment of stenosis of a tubular body part
|
US10448989B2
(en)
|
2009-04-09 |
2019-10-22 |
Virginia Tech Intellectual Properties, Inc. |
High-frequency electroporation for cancer therapy
|
US9867652B2
(en)
|
2008-04-29 |
2018-01-16 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
|
US8992517B2
(en)
|
2008-04-29 |
2015-03-31 |
Virginia Tech Intellectual Properties Inc. |
Irreversible electroporation to treat aberrant cell masses
|
AU2009243079A1
(en)
|
2008-04-29 |
2009-11-05 |
Virginia Tech Intellectual Properties, Inc. |
Irreversible electroporation to create tissue scaffolds
|
US9198733B2
(en)
|
2008-04-29 |
2015-12-01 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for electroporation-based therapies
|
US9283051B2
(en)
|
2008-04-29 |
2016-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating a treatment volume for administering electrical-energy based therapies
|
US10238447B2
(en)
|
2008-04-29 |
2019-03-26 |
Virginia Tech Intellectual Properties, Inc. |
System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
|
US10272178B2
(en)
|
2008-04-29 |
2019-04-30 |
Virginia Tech Intellectual Properties Inc. |
Methods for blood-brain barrier disruption using electrical energy
|
US10117707B2
(en)
|
2008-04-29 |
2018-11-06 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US11272979B2
(en)
|
2008-04-29 |
2022-03-15 |
Virginia Tech Intellectual Properties, Inc. |
System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
|
US11254926B2
(en)
|
2008-04-29 |
2022-02-22 |
Virginia Tech Intellectual Properties, Inc. |
Devices and methods for high frequency electroporation
|
US10245098B2
(en)
|
2008-04-29 |
2019-04-02 |
Virginia Tech Intellectual Properties, Inc. |
Acute blood-brain barrier disruption using electrical energy based therapy
|
WO2009137800A2
(en)
|
2008-05-09 |
2009-11-12 |
Angiodynamics, Inc. |
Electroporation device and method
|
US8849395B2
(en)
*
|
2008-05-30 |
2014-09-30 |
Boston Scientific Scimed, Inc. |
Guide catheter having vasomodulating electrodes
|
WO2009155526A2
(en)
|
2008-06-20 |
2009-12-23 |
Angiodynamics, Inc. |
Device and method for the ablation of fibrin sheath formation on a venous catheter
|
WO2010008834A2
(en)
|
2008-06-23 |
2010-01-21 |
Angiodynamics, Inc. |
Treatment devices and methods
|
WO2010085765A2
(en)
|
2009-01-23 |
2010-07-29 |
Moshe Meir H |
Therapeutic energy delivery device with rotational mechanism
|
WO2010093692A2
(en)
|
2009-02-10 |
2010-08-19 |
Hobbs Eamonn P |
Irreversible electroporation and tissue regeneration
|
US20100249488A1
(en)
*
|
2009-03-30 |
2010-09-30 |
MagneGene, Inc. |
Method of contactless magnetic electroporation
|
US11638603B2
(en)
|
2009-04-09 |
2023-05-02 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
US11382681B2
(en)
|
2009-04-09 |
2022-07-12 |
Virginia Tech Intellectual Properties, Inc. |
Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
|
WO2010118387A1
(en)
|
2009-04-09 |
2010-10-14 |
Virginia Tech Intellectual Properties, Inc. |
Integration of very short electric pulses for minimally to noninvasive electroporation
|
USD630321S1
(en)
|
2009-05-08 |
2011-01-04 |
Angio Dynamics, Inc. |
Probe handle
|
WO2010137021A2
(en)
|
2009-05-27 |
2010-12-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
US8903488B2
(en)
|
2009-05-28 |
2014-12-02 |
Angiodynamics, Inc. |
System and method for synchronizing energy delivery to the cardiac rhythm
|
US9895189B2
(en)
|
2009-06-19 |
2018-02-20 |
Angiodynamics, Inc. |
Methods of sterilization and treating infection using irreversible electroporation
|
US20110118732A1
(en)
|
2009-11-19 |
2011-05-19 |
The Regents Of The University Of California |
Controlled irreversible electroporation
|
RU2539991C2
(ru)
|
2009-12-16 |
2015-01-27 |
Кронтек Фарма Аб |
Впрыскивающие игла и устройство
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP4108671A1
(de)
|
2010-10-01 |
2022-12-28 |
ModernaTX, Inc. |
Modifizierte nukleoside, nukleotide und nukleinsäuren und ihre verwendungen
|
US9700368B2
(en)
|
2010-10-13 |
2017-07-11 |
Angiodynamics, Inc. |
System and method for electrically ablating tissue of a patient
|
US9428565B2
(en)
|
2011-01-31 |
2016-08-30 |
The General Hospital Corporation |
Treatment and bioluminescent visualization using multimodal TRAIL molecules
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
CN103717249B
(zh)
|
2011-06-15 |
2017-03-22 |
克洛恩泰克制药股份公司 |
注射针和装置
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
US9078665B2
(en)
|
2011-09-28 |
2015-07-14 |
Angiodynamics, Inc. |
Multiple treatment zone ablation probe
|
CN103974724B
(zh)
|
2011-10-03 |
2019-08-30 |
现代泰克斯公司 |
修饰的核苷、核苷酸和核酸及其用途
|
CA2859387A1
(en)
|
2011-12-16 |
2013-06-20 |
Moderna Therapeutics, Inc. |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US9414881B2
(en)
|
2012-02-08 |
2016-08-16 |
Angiodynamics, Inc. |
System and method for increasing a target zone for electrical ablation
|
AU2013243951A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of secreted proteins
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
WO2014035474A1
(en)
|
2012-08-30 |
2014-03-06 |
The General Hospital Corporation |
Compositions and methods for treating cancer
|
WO2014064534A2
(en)
|
2012-10-05 |
2014-05-01 |
Chrontech Pharma Ab |
Injection needle, device, immunogenic compositions and method of use
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドModernaTX,Inc. |
化学修飾mRNA
|
US9888956B2
(en)
|
2013-01-22 |
2018-02-13 |
Angiodynamics, Inc. |
Integrated pump and generator device and method of use
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
EP2968606B1
(de)
|
2013-03-15 |
2020-10-07 |
Loma Linda University |
Behandlung von autoimmunerkrankungen
|
CA2913155A1
(en)
|
2013-05-21 |
2014-11-27 |
President And Fellows Of Harvard College |
Engineered heme-binding compositions and uses thereof
|
EA201690675A1
(ru)
|
2013-10-03 |
2016-08-31 |
Модерна Терапьютикс, Инк. |
Полинуклеотиды, кодирующие рецептор липопротеинов низкой плотности
|
US10166321B2
(en)
|
2014-01-09 |
2019-01-01 |
Angiodynamics, Inc. |
High-flow port and infusion needle systems
|
US10471254B2
(en)
|
2014-05-12 |
2019-11-12 |
Virginia Tech Intellectual Properties, Inc. |
Selective modulation of intracellular effects of cells using pulsed electric fields
|
WO2016100325A1
(en)
|
2014-12-15 |
2016-06-23 |
Virginia Tech Intellectual Properties, Inc. |
Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
|
EP3283529B1
(de)
|
2015-04-17 |
2023-06-07 |
The General Hospital Corporation |
Wirkstoffe, systeme und verfahren zur behandlung von krebs
|
US10660691B2
(en)
|
2015-10-07 |
2020-05-26 |
Angiodynamics, Inc. |
Multiple use subassembly with integrated fluid delivery system for use with single or dual-lumen peristaltic tubing
|
US10233419B2
(en)
|
2016-06-30 |
2019-03-19 |
Zymergen Inc. |
Apparatuses and methods for electroporation
|
AU2017357919A1
(en)
|
2016-11-09 |
2019-06-20 |
Sigma Genetics, Inc. |
Systems, devices, and methods for electroporation induced by magnetic fields
|
US10905492B2
(en)
|
2016-11-17 |
2021-02-02 |
Angiodynamics, Inc. |
Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
|
US11607537B2
(en)
|
2017-12-05 |
2023-03-21 |
Virginia Tech Intellectual Properties, Inc. |
Method for treating neurological disorders, including tumors, with electroporation
|
US11311329B2
(en)
|
2018-03-13 |
2022-04-26 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
|
US11925405B2
(en)
|
2018-03-13 |
2024-03-12 |
Virginia Tech Intellectual Properties, Inc. |
Treatment planning system for immunotherapy enhancement via non-thermal ablation
|
US11950835B2
(en)
|
2019-06-28 |
2024-04-09 |
Virginia Tech Intellectual Properties, Inc. |
Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy
|
KR20220160042A
(ko)
|
2020-03-27 |
2022-12-05 |
스벤스카 박신파브리셴 프로둑숀 아베 |
코로나바이러스의 치료 및 예방을 위한 조성물 및 방법
|
US20230295244A1
(en)
|
2021-09-29 |
2023-09-21 |
Svenska Vaccinfabriken Produktion Ab |
Compositions and methods for treating and preventing coronaviruses
|